These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3977920)

  • 1. Desensitization of human platelets by platelet activating factor.
    Chesney CM; Pifer DD; Huch KM
    Biochem Biophys Res Commun; 1985 Feb; 127(1):24-30. PubMed ID: 3977920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
    Kornecki E; Ehrlich YH; Lenox RH
    Science; 1984 Dec; 226(4681):1454-6. PubMed ID: 6150550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
    Ostermann G; Till U; Thielmann K
    Thromb Res; 1983 Apr; 30(2):127-36. PubMed ID: 6408754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional zinc increases platelet reactivity.
    Marx G; Krugliak J; Shaklai M
    Am J Hematol; 1991 Nov; 38(3):161-5. PubMed ID: 1951315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF-acether may not mediate the third pathway of platelet aggregation since self-desensitization reduces the effects of low thrombin but enhances those of convulxin.
    Wal F; Joseph D; Touqui L; Vargaftig BB
    Thromb Haemost; 1985 Feb; 53(1):99-104. PubMed ID: 3992525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of platelet activating factor-amidophosphonate (PAF-AP), a novel phosphonolipid selective inhibitor of platelet activating factor (PAF).
    Steiner M; Landolfi R; Motola NC; Turcotte JG
    Biochem Biophys Res Commun; 1985 Dec; 133(3):851-5. PubMed ID: 3936503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of platelet activating factor on rat platelets in vivo.
    Klee A; Schmid-Schönbein GW; Seiffge D
    Eur J Pharmacol; 1991 Dec; 209(3):223-30. PubMed ID: 1797563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant hirudin on cytosolic Ca2+ concentrations using different platelet stimulators.
    Kirchmaier CM; Bellinger OK; Schulz B; Breddin HK
    Haemostasis; 1991; 21 Suppl 1():121-6. PubMed ID: 1894187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activating factor and sheep platelets: a sensitive new bioassay.
    Moon DG; van der Zee H; Morton KD; Krasodomski JA; Kaplan JE; Fenton JW
    Thromb Res; 1990 Feb; 57(4):551-64. PubMed ID: 2326773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degranulation of rabbit platelets with PAF-acether: a new procedure for unravelling the mode of action of platelet-activating substances.
    Vargaftig BB; Joseph D; Marlas G; Chevance LG
    Thromb Haemost; 1982 Aug; 48(1):67-71. PubMed ID: 7135345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation by phospholipase-A.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Thromb Res; 1976 Oct; 9(4):335-44. PubMed ID: 982355
    [No Abstract]   [Full Text] [Related]  

  • 13. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
    Steen VM; Holmsen H; Aarbakke G
    Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The thrombocyte-activation factor and endotoxin-induced thrombocyte activation].
    Lomazova KD; Poliakova AM; Astrina OS; Tsukerman DB
    Biull Eksp Biol Med; 1989 May; 107(5):538-40. PubMed ID: 2500157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
    Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
    Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation of killer whale platelets.
    Patterson WR; Dalton LM; McGlasson DL; Cissik JH
    Thromb Res; 1993 May; 70(3):225-31. PubMed ID: 8327987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure to detect platelet-activating factor using the splenectomized mouse bioassay.
    Scodras JM; Betteridge KJ; Croy BA; Johnstone IB; Rieger D
    J Reprod Fertil; 1991 Jul; 92(2):483-94. PubMed ID: 1886104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen.
    Hornby EJ; Perry CR
    Thromb Haemost; 1983 Aug; 50(2):586-7. PubMed ID: 6636035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of platelet desensitization in pregnancy-induced hypertension is dependent on the agonist used.
    Ahmed Y; Sullivan MH; Elder MG
    Thromb Haemost; 1991 May; 65(5):474-7. PubMed ID: 1908139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of platelet inhibitor present in the melon (Cucurbitacea cucumis melo).
    Altman R; Rouvier J; Weisenberger H
    Thromb Haemost; 1985 Jun; 53(3):312-3. PubMed ID: 3931281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.